Amy Elazzouzi
Vermogen: 901 808 $ op 30-09-2026
Vermogen: 901 808 $ op 30-09-2026
Amy Elazzouzi is currently Principal Financial Officer, Secretary & Treasurer at Aura Biosciences, Inc. since 2026.
Former positions include Director-Finance & Operations at Kew, Inc. and Controller at AVEO Pharmaceuticals, Inc. Education includes an MBA from Northeastern University and an undergraduate degree from Regis College.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,14% | 01-09-2026 | 143.600 ( 0,14% ) | 901 808 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AURA BIOSCIENCES, INC. | Financieel Directeur/CFO | 02-09-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Financieel Directeur/CFO | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Aura Biosciences, Inc.
Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regis College
Regis College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Health Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau